Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Vitamin D

What does the research say about Vitamin D?

43 health outcomes synthesised

Pillser's research synthesis covers 43 health outcomes related to vitamin D supplementation. The strongest evidence, supported by 16 studies, confirms that vitamin D consistently increases 25-hydroxyvitamin D levels, with effects typically observed after 8–12 weeks using doses ranging from 240 to 4,000 IU per day. Moderate evidence further links vitamin D to improvements in insulin sensitivity, inflammatory markers, and quality of life, particularly in deficient or clinical populations.

Strongest evidence: The most robust finding comes from 16 studies showing that vitamin D supplementation increases 25-hydroxyvitamin D levels, with 14 reporting beneficial effects (evidence strength: high). Moderate evidence supports improved insulin sensitivity (6 of 9 studies beneficial, doses 1000–4000 IU/day), reduced C-reactive protein (5 of 8 studies, moderate effect), reduced interleukin-6 (5 of 8 studies, moderate effect), and improved quality of life (6 of 6 studies, small effect). Additional moderate-strength outcomes include reduced triglycerides (4 of 7 studies), reduced tumor necrosis factor alpha (3 of 5 studies), reduced HOMA-IR (3 of 5 studies), and reduced parathyroid hormone (3 of 4 studies).

Mixed or weaker evidence: No outcomes reached low or very low evidence strength within the top 12 syntheses. However, several moderate-strength outcomes show inconsistency: reduced depression symptoms (3 of 4 studies beneficial, but with small effects and methodological limitations), reduced triglycerides (3 of 7 studies neutral), and reduced interleukin-6 (3 of 8 studies neutral). The evidence tends to be more consistent in clinical or deficient populations.

Effective dose patterns: Across outcomes, effective daily doses commonly fall between 1,000 and 4,000 IU per day. For insulin sensitivity, the range is 1000–4000 IU/day; for quality of life, 4000 IU/day or 60,000 IU/week; for parathyroid hormone reduction, up to 5,000 IU/day; and for insulin levels, 1000 IU/day. Weekly bolus doses (e.g., 50,000–60,000 IU) were also used in some studies on 25-hydroxyvitamin D levels and quality of life.

Population insights: The benefits of vitamin D supplementation are most consistently observed in individuals with low baseline vitamin D status and in clinical populations, such as those with PCOS, gestational diabetes, type 2 diabetes, obesity, metabolic conditions, inflammatory diseases (e.g., rheumatoid arthritis), and older adults. Effects are often modest or absent in replete or healthy populations. Specific groups studied include women with PCOS or gestational diabetes, overweight/obese children, and patients with Alzheimer’s disease, fibromyalgia, or chronic urticaria.

Notable caveats: Across syntheses, publication bias is a recurring concern—null results are less likely to be published, potentially overestimating benefits. Many studies combined vitamin D with other supplements (e.g., magnesium, whey protein), making it difficult to isolate its independent effect. Dose and form reporting were inconsistent; where specified, vitamin D3 (cholecalciferol) was used. Most trials lasted 8–12 weeks, so shorter durations may not capture effects. Several outcomes had small sample sizes or neutral studies, and clinical significance of small effect sizes remains uncertain.

Frequently asked

  • What is vitamin D good for according to research?
    Research consistently shows vitamin D increases 25-hydroxyvitamin D levels (16 studies, high evidence). Moderate evidence supports benefits for insulin sensitivity, reducing inflammatory markers (CRP, IL-6, TNF-α), triglycerides, HOMA-IR, parathyroid hormone, and improving quality of life—particularly in clinical or vitamin D-deficient populations.
  • What dose of vitamin D is typically used in studies?
    Effective daily doses commonly range from 1,000 to 4,000 IU per day across outcomes, with some studies using weekly bolus doses of 50,000–60,000 IU. The most consistent dose range for insulin sensitivity is 1000–4000 IU/day, while quality of life improvements were seen at 4000 IU/day or 60,000 IU/week.
  • Who benefits most from vitamin D supplementation?
    Benefits are strongest in individuals with low baseline vitamin D levels and clinical populations, such as those with PCOS, gestational diabetes, type 2 diabetes, obesity, metabolic conditions, inflammatory diseases (e.g., rheumatoid arthritis), and older adults. Effects are often modest or absent in healthy individuals with sufficient vitamin D levels.
  • Are there caveats or limitations in the research on vitamin D?
    Yes. Publication bias is a concern—null results may be underrepresented. Many studies combined vitamin D with other supplements, complicating attribution. Dose and form reporting was inconsistent, and most trials lasted 8–12 weeks. The evidence tends to be stronger in deficient or clinical populations, limiting generalizability.
  • Does vitamin D help with depression symptoms?
    Three of four studies reported small beneficial effects of vitamin D on depression symptoms, with evidence strongest in elderly adults (aged 65+) and adolescents. However, the evidence base is small, effect sizes are modest, and one systematic review found neutral results with methodological limitations.
  • Does vitamin D reduce inflammation?
    Yes. Five studies with moderate evidence show vitamin D reduces inflammation, with small-to-moderate effect sizes. Specific inflammatory markers improved include C-reactive protein (5 of 8 studies), interleukin-6 (5 of 8 studies), and tumor necrosis factor alpha (3 of 5 studies). Effects are most consistent in clinical populations with underlying inflammatory conditions.

Most-studied combinations with Vitamin D

most supplement research is combination research
  • Very low evidence

    Of the 3 studies examining the combination of vitamin D and vitamin C for cognitive function, 1 reported a beneficial effect while 2 found neutral effects. The single beneficial finding came from a systematic review that did not isolate the combination, and the other two reviews/meta-analyses found no significant effect. Compared to vitamin D alone (which showed neutral effects across 3 solo studies), the combination evidence is similarly inconclusive. No consistent dose, form, or duration data were reported across studies.

  • Joint Mobility Factors

    By Michael's Naturopathic

    4.5 (2 reviews)
    Out of Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    Out
    iHerb
    $34.63
    In
    Vitacost
    $-
    Out
    Vitamin Shoppe
    $-
    Out
  • D-3

    By Nature's Life

    4.6 (8 reviews)
    In Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    Out
    iHerb
    $10.49
    In
    Vitacost
    $10.49
    In
    Vitamin Shoppe
    $-
    Out
  • Men's 45+ 1-Daily Multi

    By Emerald Laboratories

    4.8 (282 reviews)
    Out of Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    Out
    iHerb
    $21.56
    In
    Vitacost
    $21.56
    In
    Vitamin Shoppe
    $23.71
    In
  • Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    Out
    iHerb
    $9.76
    In
    Vitacost
    $-
    Out
    Vitamin Shoppe
    $-
    Out
  • CatchFree Omega

    By Wiley's Finest

    4.7 (38 reviews)
    Out of Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    Out
    iHerb
    $31.99
    In
    Vitacost
    $36.79
    In
    Vitamin Shoppe
    $-
    Out
  • D3 + K2

    By Zhou Nutrition

    4.7 (749 reviews)
    In Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    Out
    iHerb
    $15.04
    In
    Vitacost
    $15.04
    In
    Vitamin Shoppe
    $19.99
    In
Back to top